acrolein has been researched along with simvastatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, J; Chen, L; Chen, P; Chen, YJ; Liu, DS; Sun, BB; Wang, HX; Wang, T; Wang, X; Wen, FQ; Xu, D | 1 |
Bhatnagar, A; Conklin, DJ; Haberzettl, P; Juvan, P; Prough, RA; Rezen, T; Rozman, D; Srivastava, S | 1 |
2 other study(ies) available for acrolein and simvastatin
Article | Year |
---|---|
Simvastatin attenuates acrolein-induced mucin production in rats: involvement of the Ras/extracellular signal-regulated kinase pathway.
Topics: Acrolein; Animals; Anti-Inflammatory Agents, Non-Steroidal; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Goblet Cells; GTP Phosphohydrolases; Humans; Hyperplasia; Lung; Male; Mevalonic Acid; Mucin 5AC; Phosphorylation; Pneumonia; Prenylation; ras Proteins; Rats; Rats, Sprague-Dawley; Simvastatin | 2010 |
Acrolein-induced dyslipidemia and acute-phase response are independent of HMG-CoA reductase.
Topics: Acrolein; Acute-Phase Reaction; Animals; Apolipoproteins E; Cholesterol; Dyslipidemias; Gene Expression Regulation; Hydroxymethylglutaryl CoA Reductases; Liver; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Serum Amyloid A Protein; Simvastatin; Toxicity Tests, Acute; Toxicity Tests, Chronic; Triglycerides; Xenobiotics | 2011 |